Related Experiment Video
Updated: Apr 26, 2026
11:01
Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
12.6K
Episodic memory decline in Huntington's disease, a binding deficit?
Mohamad El Haj1, Marie Caillaud2, Luciano Fasotti3
1LUNAM Université, Laboratoire de Psychologie des Pays de la Loire, Université de Nantes et Angers, France Neuropsychology and Auditory Cognition, Department of Psychology, University of Lille, France Laboratoire Epsylon, EA 4556, Université Paul-Valery, Montpellier III, France.
Journal of Huntington'S Disease
|July 27, 2014
Summary
Huntington's disease (HD) patients show episodic memory decline linked to impaired binding, a key cognitive mechanism. This suggests damage to brain circuitry affects the ability to form complex memories.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Neurology
Background:
- Huntington's disease (HD) is a neurodegenerative disorder.
- Episodic memory deterioration is a hallmark symptom of HD.
Purpose of the Study:
- Investigate cognitive mechanisms underlying episodic memory decline in HD.
- Test executive function hypotheses: binding and inhibition.
Main Methods:
- Assessed 15 HD patients and 18 matched controls.
- Utilized a neuropsychological battery for episodic memory and executive functions.
- Specifically evaluated binding and inhibition capacities.
Main Results:
- Episodic memory decline in HD patients correlated significantly with impaired binding performance.
- No significant relationship was found between episodic decline and inhibition performance.
Conclusions:
- HD patients exhibit deficits in associative and integrative memory mechanisms.
- Impaired binding affects the formation of complex episodic representations.
- Frontal-hippocampal circuitry damage in HD likely causes these memory impairments.
Related Concept Videos
01:21Huntington Disease l: Introduction
68
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
68
01:29Alzheimer Disease l: Introduction
19
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
01:19Role of Hippocampus in Memory
2.0K
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
2.0K
01:22Dementia l: Introduction
29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
01:23Alzheimer Disease ll: Pathophysiology
27
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
27
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K